Skip to main content
OpenTrials

Clinical trial condition

Advanced Solid Tumors

Explore clinical trials studying Advanced Solid Tumors. Study availability and eligibility vary by location and protocol.

609 public trials 183 recruiting studies
Refine in advanced search Browse all conditions

Advanced Solid Tumors trial results

Completed

Bioequivalence of 2 Formulations of TKI258 in Patients With Advanced Solid Tumors

NCT01421004

Conditions
Advanced Solid Tumors, Excluding Breast Cancer, Neoplasms
Locations
  • City of Hope National Medical Center SC-2 Duarte, California, United States
  • University of California at Los Angeles UCLA LeConte Location Los Angeles, California, United States
  • University of California San Francisco UCSF (SC) San Francisco, California, United States
  • Florida Cancer Specialists Sarasota Office Fort Myers, Florida, United States
View all 14 locations
View Trial Details
Completed

Dose Finding Study of RAD001 (Everolimus, Afinitor®) in Combination With BEZ235 in Patients With Advanced Solid Tumors

NCT01482156

Conditions
Adenocarcinoma, Advanced Solid Tumors, Breast Diseases, +20 more
Locations
  • Highlands Oncology Group Dept of Highlands Oncology Grp Fayetteville, Arkansas, United States
  • Washington University School of Medicine Washington University (16) St Louis, Missouri, United States
  • Medical University of South Carolina SC Charleston, South Carolina, United States
  • Novartis Investigative Site Wilrijk, Belgium
View Trial Details
Completed

Pharmacokinetics and Safety of Panobinostat in Patients With Advanced Solid Tumors and Various Degrees of Hepatic Function

NCT01007968

Conditions
Advanced Solid Tumors
Locations
  • University of Utah / Huntsman Cancer Institute Salt Lake City, Utah, United States
  • Novartis Investigative Site Leiden, Netherlands
  • Novartis Investigative Site Lund, Sweden
  • Novartis Investigative Site Stockholm, Sweden
View Trial Details
Completed

Phase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid Tumors

NCT01576666

Conditions
Advanced Pancreatic Adenocarcinoma, Advanced Solid Tumors, Astrocytoma, +35 more
Locations
  • Cedars Sinai Medical Center SC Los Angeles, California, United States
  • University of California San Francisco UCSF (SC) San Francisco, California, United States
  • H. Lee Moffitt Cancer Center & Research Institute Moffitt 4 Tampa, Florida, United States
  • Dana Farber Cancer Institute Dana SC Boston, Massachusetts, United States
View all 23 locations
View Trial Details
Completed

Study to Evaluate Panobinostat (DACi) Pharmacokinetics and Safety in Solid Tumors and Varying Renal Function

NCT00997399

Conditions
Advanced Solid Tumors
Locations
  • University of Utah / Huntsman Cancer Institute Salt Lake City, Utah, United States
  • Novartis Investigative Site Leiden, Netherlands
  • Novartis Investigative Site Utrecht, Netherlands
  • Novartis Investigative Site Sankt Gallen, Switzerland
View Trial Details
Completed

A Dose Finding and Safety Study of Oral LEQ506 in Patients With Advanced Solid Tumors

NCT01106508

Conditions
Advanced Solid Tumors, Carcinoma, Carcinoma, Basal Cell, +17 more
Locations
  • University of California at Los Angeles UCLA LeConte Location Los Angeles, California, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Novartis Investigative Site Utrecht, Netherlands
  • Novartis Investigative Site Zurich, Switzerland
View Trial Details

Related conditions